- call +1-201-465-4211
- email sales@mrinsights.biz
Scope of the Report:
This report studies the Biologics Safety Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Safety Testing market by product type and applications/end industries.
Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
The global Biologics Safety Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Safety Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Lonza Group
Charles River
Merck
SGS
WuXi AppTec
Thermo Fisher Scientific
Sartorius
Cytovance Biologics
Pace Analytical Services
Toxikon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others
Market Segment by Applications, can be divided into
Vaccine Development
Blood Products Testing
Cellular & Gene Therapy
Tissue and Tissue-Related Products Testing
Stem Cell Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Biologics Safety Testing Market Overview
1.1 Product Overview and Scope of Biologics Safety Testing
1.2 Classification of Biologics Safety Testing by Types
1.2.1 Global Biologics Safety Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Biologics Safety Testing Revenue Market Share by Types in 2017
1.2.3 Endotoxin Tests
1.2.4 Sterility Tests
1.2.5 Cell Line Authentication and Characterization Tests
1.2.6 Bioburden Tests
1.2.7 Cell Line Authentication
1.2.8 Residual Host Contaminant Detection Tests
1.2.9 Adventitious Agent Detection Tests
1.2.10 Others
1.3 Global Biologics Safety Testing Market by Application
1.3.1 Global Biologics Safety Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Vaccine Development
1.3.3 Blood Products Testing
1.3.4 Cellular & Gene Therapy
1.3.5 Tissue and Tissue-Related Products Testing
1.3.6 Stem Cell Research
1.4 Global Biologics Safety Testing Market by Regions
1.4.1 Global Biologics Safety Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Biologics Safety Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Safety Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Safety Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Biologics Safety Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Safety Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Biologics Safety Testing (2013-2023)
2 Manufacturers Profiles
2.1 Lonza Group
2.1.1 Business Overview
2.1.2 Biologics Safety Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lonza Group Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Charles River
2.2.1 Business Overview
2.2.2 Biologics Safety Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Charles River Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Biologics Safety Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 SGS
2.4.1 Business Overview
2.4.2 Biologics Safety Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SGS Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 WuXi AppTec
2.5.1 Business Overview
2.5.2 Biologics Safety Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 WuXi AppTec Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Biologics Safety Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sartorius
2.7.1 Business Overview
2.7.2 Biologics Safety Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sartorius Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cytovance Biologics
2.8.1 Business Overview
2.8.2 Biologics Safety Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cytovance Biologics Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pace Analytical Services
2.9.1 Business Overview
2.9.2 Biologics Safety Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pace Analytical Services Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Toxikon
2.10.1 Business Overview
2.10.2 Biologics Safety Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Toxikon Biologics Safety Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologics Safety Testing Market Competition, by Players
3.1 Global Biologics Safety Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Safety Testing Players Market Share
3.2.2 Top 10 Biologics Safety Testing Players Market Share
3.3 Market Competition Trend
4 Global Biologics Safety Testing Market Size by Regions
4.1 Global Biologics Safety Testing Revenue and Market Share by Regions
4.2 North America Biologics Safety Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Biologics Safety Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologics Safety Testing Revenue and Growth Rate (2013-2018)
4.5 South America Biologics Safety Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologics Safety Testing Revenue and Growth Rate (2013-2018)
5 North America Biologics Safety Testing Revenue by Countries
5.1 North America Biologics Safety Testing Revenue by Countries (2013-2018)
5.2 USA Biologics Safety Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Biologics Safety Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Biologics Safety Testing Revenue and Growth Rate (2013-2018)
6 Europe Biologics Safety Testing Revenue by Countries
6.1 Europe Biologics Safety Testing Revenue by Countries (2013-2018)
6.2 Germany Biologics Safety Testing Revenue and Growth Rate (2013-2018)
6.3 UK Biologics Safety Testing Revenue and Growth Rate (2013-2018)
6.4 France Biologics Safety Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Biologics Safety Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Biologics Safety Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Biologics Safety Testing Revenue by Countries
7.1 Asia-Pacific Biologics Safety Testing Revenue by Countries (2013-2018)
7.2 China Biologics Safety Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Biologics Safety Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Biologics Safety Testing Revenue and Growth Rate (2013-2018)
7.5 India Biologics Safety Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biologics Safety Testing Revenue and Growth Rate (2013-2018)
8 South America Biologics Safety Testing Revenue by Countries
8.1 South America Biologics Safety Testing Revenue by Countries (2013-2018)
8.2 Brazil Biologics Safety Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Biologics Safety Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Biologics Safety Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Biologics Safety Testing by Countries
9.1 Middle East and Africa Biologics Safety Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biologics Safety Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Biologics Safety Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Biologics Safety Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biologics Safety Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Biologics Safety Testing Revenue and Growth Rate (2013-2018)
10 Global Biologics Safety Testing Market Segment by Type
10.1 Global Biologics Safety Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Biologics Safety Testing Market Forecast by Type (2018-2023)
10.3 Endotoxin Tests Revenue Growth Rate (2013-2023)
10.4 Sterility Tests Revenue Growth Rate (2013-2023)
10.5 Cell Line Authentication and Characterization Tests Revenue Growth Rate (2013-2023)
10.6 Bioburden Tests Revenue Growth Rate (2013-2023)
10.7 Cell Line Authentication Revenue Growth Rate (2013-2023)
10.8 Residual Host Contaminant Detection Tests Revenue Growth Rate (2013-2023)
10.9 Adventitious Agent Detection Tests Revenue Growth Rate (2013-2023)
10.10 Others Revenue Growth Rate (2013-2023)
11 Global Biologics Safety Testing Market Segment by Application
11.1 Global Biologics Safety Testing Revenue Market Share by Application (2013-2018)
11.2 Biologics Safety Testing Market Forecast by Application (2018-2023)
11.3 Vaccine Development Revenue Growth (2013-2018)
11.4 Blood Products Testing Revenue Growth (2013-2018)
11.5 Cellular & Gene Therapy Revenue Growth (2013-2018)
11.6 Tissue and Tissue-Related Products Testing Revenue Growth (2013-2018)
11.7 Stem Cell Research Revenue Growth (2013-2018)
12 Global Biologics Safety Testing Market Size Forecast (2018-2023)
12.1 Global Biologics Safety Testing Market Size Forecast (2018-2023)
12.2 Global Biologics Safety Testing Market Forecast by Regions (2018-2023)
12.3 North America Biologics Safety Testing Revenue Market Forecast (2018-2023)
12.4 Europe Biologics Safety Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biologics Safety Testing Revenue Market Forecast (2018-2023)
12.6 South America Biologics Safety Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biologics Safety Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Biologics Safety Testing Picture
Table Product Specifications of Biologics Safety Testing
Table Global Biologics Safety Testing and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
